|
시장보고서
상품코드
1652018
세계의 CRISPR 및 Cas 유전자 시장 : 시장 규모, 점유율, 동향, 업계 분석(종류별, 용도별, 최종사용자별, 지역별), 예측(2025-2034년)CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report: By Type, Application, End User, and Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 CRISPR 및 Cas 유전자 시장 규모는 2034년까지 228억 2,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
CRISPR 및 Cas 유전자 시장에는 의료, 농업, 생명공학 분야에서 유전자 편집 응용을 위한 CRISPR/Cas 기술의 사용이 포함됩니다. 이 기술은 DNA의 정확한 변형이 가능하여 유전자 연구, 질병 치료, 작물 개량에 진보를 가져올 수 있습니다. 이 시장은 맞춤형 의료, 유전자 치료, 농업 관행에 혁명을 일으킬 수 있는 잠재력을 가지고 있어 빠르게 성장하고 있습니다. 주요 촉진요인으로는 유전자 연구에 대한 투자 증가, 유전자 치료에 대한 수요 증가, 보다 지속가능한 농업 솔루션의 필요성 등이 있습니다. 그러나 윤리적 우려와 규제 장벽이 시장 확대에 영향을 미칠 수 있습니다.
CRISPR 및 Cas 유전자 시장의 수요 증가는 유전자 편집 기술의 발전, 유전자 연구 투자 증가, 의료, 농업, 생명공학 분야에서의 응용 분야 확대에 기인합니다. 주요 촉진요인으로는 유전성 질환을 치료하기 위한 CRISPR 기반 치료의 가능성, 강화된 형질을 가진 유전자 변형 작물에 대한 수요 증가, 효율적인 신약 개발 도구에 대한 수요 증가 등이 있습니다. 희귀질환의 유전자 치료, 지속가능한 식량 생산을 위한 농업 생명공학에 CRISPR의 통합에 있습니다. 주요 동향으로는 차세대 CRISPR 기술로의 전환, 유전자 치료 임상시험의 증가, 생명공학 기업과 학술 기관의 연구 협력 확대 등을 들 수 있습니다.
CRISPR 및 Cas 유전자 시장 : 분석 개요
제품 부문이 가장 큰 시장 점유율을 차지하고 있으며, 유전자 편집 연구 및 응용을 위한 CRISPR 도구, 시약, 키트에 대한 높은 수요가 주도하고 있습니다. 서비스 부문은 CRISPR 관련 연구개발을 CRO(임상시험수탁기관)에 아웃소싱하는 사례가 증가하면서 가장 높은 성장세를 보이고 있습니다.
바이오메디컬 분야는 유전성 질환, 암, 맞춤형 의료를 목표로 하는 유전자 치료에 CRISPR 활용이 증가하면서 시장을 주도하고 있습니다. 농업 분야는 CRISPR 기술이 작물 형질 강화 및 식량 안보 개선에 활용되면서 가장 빠르게 성장하고 있습니다.
CRO와 CDMO 부문이 가장 빠르게 성장하고 있는 이유는 CRO와 CDMO가 생명공학 및 제약기업들이 유전자 질환 및 신약개발을 위한 CRISPR 기반 치료에 많은 투자를 하고 있기 때문입니다. 중요한 역할을 하고 있기 때문입니다.
북미는 강력한 생명공학 부문, 대규모 R&D 투자, 유전자 편집 기술에 대한 규제 당국의 지원으로 시장을 주도하고 있습니다. 아시아태평양은 가장 높은 성장률을 보이는 지역으로 중국, 인도와 같은 국가에서 CRISPR 기술이 빠르게 채택되고 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 분석 방법
제4장 CRISPR 및 Cas 유전자 시장 인사이트
- 시장 현황
- CRISPR 및 Cas 유전자 시장 역학
- 성장 촉진요인과 기회
- CRISPR 기반 치료 최종사용자의 진보
- 농업 바이오 애플리케이션의 CRISPR 이용 증가
- 성장 억제요인과 과제
- 배송 과제
- 성장 촉진요인과 기회
- PESTLE 분석
- CRISPR 및 Cas 유전자 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 CRISPR 및 Cas 유전자 시장 : 종류별
- 주요 분석 결과
- 소개
- 제품
- 서비스
제6장 세계의 CRISPR 및 Cas 유전자 시장 : 용도별
- 주요 분석 결과
- 소개
- 바이오메디컬
- 농업
제7장 세계의 CRISPR 및 Cas 유전자 시장 : 최종사용자별
- 주요 분석 결과
- 소개
- 바이오테크놀러지·제약 기업
- 학술기관·정부계 조사기관
- CRO·CDMO
제8장 세계의 CRISPR 및 Cas 유전자 시장 : 지역별
- 주요 분석 결과
- 소개
- CRISPR 및 Cas 유전자 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 종류별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종사용자별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 종류별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 종류별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 종류별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 종류별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 사업 확대·기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Caribou Biosciences
- Sangamo Therapeutics
- Agilent Technologies
- Addgene
- Thermo Fisher Scientific
- Illumina
- Life Technologies
- Precision Biosciences
- Beam Therapeutics
- Cellectis
- Gene Editing Technologies
- Horizon Discovery
The global CRISPR & Cas genes market size is expected to reach USD 22.82 billion by 2034, according to a new study by Polaris Market Research. The report "CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report: By Type (Products and Services), Application (Biomedical and Agricultural), End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The CRISPR & Cas genes market involves the use of CRISPR-Cas technology for gene editing applications in medicine, agriculture, and biotechnology. This technology allows precise modifications to DNA, enabling advancements in genetic research, disease treatment, and crop improvement. The market is experiencing rapid growth due to its potential to revolutionize personalized medicine, gene therapies, and agricultural practices. Key drivers include increasing investment in genetic research, rising demand for gene therapies, and the need for more sustainable agricultural solutions. However, ethical concerns and regulatory hurdles may affect market expansion.
The rising CRISPR & Cas genes market demand is attributed to advancements in gene-editing technologies, increased investments in genetic research, and expanding applications in healthcare, agriculture, and biotechnology. Key drivers include the potential for CRISPR-based therapies to treat genetic disorders, the growing demand for genetically modified crops with enhanced traits, and the rising need for efficient drug discovery tools. CRISPR & Cas genes market opportunities lie in the development of personalized medicine, gene therapies for rare diseases, and CRISPR's integration into agricultural biotechnology for sustainable food production. Major trends include the shift toward next-generation CRISPR technologies, an increase in clinical trials for gene therapies, and expanding research collaborations between biotech firms and academic institutions.
CRISPR & Cas Genes Market Report Highlights
The products segment holds the largest market share, driven by high demand for CRISPR tools, reagents, and kits for gene-editing research and applications. The services segment is experiencing the highest growth, fueled by increasing outsourcing of CRISPR-related research and development to contract research organizations (CROs).
The biomedical segment dominates the market, driven by the increasing use of CRISPR for gene therapies targeting genetic disorders, cancer, and personalized medicine. The agricultural segment is the fastest-growing, as CRISPR technologies are being leveraged to enhance crop traits and improve food security.
Biotechnology & pharmaceutical companies hold the largest share, investing heavily in CRISPR-based therapies for genetic diseases and drug discovery. The CRO and CDMO segment is growing the fastest, as these organizations play a critical role in advancing clinical trials and gene-editing services for biotech firms.
North America dominates the market, driven by a strong biotechnology sector, significant R&D investments, and regulatory support for gene-editing technologies. Asia-Pacific is the highest-growing region, with rapid adoption of CRISPR technologies in countries like China and India, focusing on both healthcare and agricultural applications.
Polaris Market Research has segmented the CRISPR & Cas Genes market report on the basis of type, application, end user, and region:
By Type Outlook (Revenue - USD Billion, 2020-2034)
- Products
- Services
By Application Outlook (Revenue - USD Billion, 2020-2034)
- Biomedical
- Agricultural
By End User Outlook (Revenue - USD Billion, 2020-2034)
- Biotechnology & Pharmaceutical Companies
- Academics & Government Research Institutes
- Contract Research Organizations (CRO) & CDMOs
By Regional Outlook (Revenue - USD Billion, 2020-2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. Global CRISPR & Cas Genes Market Insights
- 4.1. CRISPR & Cas Genes Market - Market Snapshot
- 4.2. CRISPR & Cas Genes Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Advancements in CRISPR-Based Therapeutic End Users
- 4.2.1.2. Increasing Use of CRISPR in Agricultural BioApplication
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Delivery challenges
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. CRISPR & Cas Genes Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global CRISPR & Cas Genes Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 5.3. Product
- 5.3.1. Global CRISPR & Cas Genes Market, by Product, by Region, 2020-2034 (USD Billion)
- 5.4. Services
- 5.4.1. Global CRISPR & Cas Genes Market, by Services, by Region, 2020-2034 (USD Billion)
6. Global CRISPR & Cas Genes Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 6.3. Biomedical
- 6.3.1. Global CRISPR & Cas Genes Market, by Biomedical, by Region, 2020-2034 (USD Billion)
- 6.4. Agricultural
- 6.4.1. Global CRISPR & Cas Genes Market, by Agricultural, by Region, 2020-2034 (USD Billion)
7. Global CRISPR & Cas Genes Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 7.3. Biotechnology & Pharmaceutical Companies
- 7.3.1. Global CRISPR & Cas Genes Market, by Biotechnology & Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
- 7.4. Academics & Government Research Institutes
- 7.4.1. Global CRISPR & Cas Genes Market, by Academics & Government Research Institutes, by Region, 2020-2034 (USD Billion)
- 7.5. Contract Research Organizations (CRO) & CDMOs
- 7.5.1. Global CRISPR & Cas Genes Market, by Contract Research Organizations (CRO) & CDMOs, by Region, 2020-2034 (USD Billion)
8. Global CRISPR & Cas Genes Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. CRISPR & Cas Genes Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. CRISPR & Cas Genes Market - North America
- 8.3.1. North America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. CRISPR & Cas Genes Market - U.S.
- 8.3.4.1. U.S.: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. CRISPR & Cas Genes Market - Canada
- 8.3.5.1. Canada: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4. CRISPR & Cas Genes Market - Europe
- 8.4.1. Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. CRISPR & Cas Genes Market - UK
- 8.4.4.1. UK: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.4.4.2. UK: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.4.4.3. UK: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. CRISPR & Cas Genes Market - France
- 8.4.5.1. France: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.4.5.2. France: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.4.5.3. France: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. CRISPR & Cas Genes Market - Germany
- 8.4.6.1. Germany: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. CRISPR & Cas Genes Market - Italy
- 8.4.7.1. Italy: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. CRISPR & Cas Genes Market - Spain
- 8.4.8.1. Spain: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. CRISPR & Cas Genes Market - Netherlands
- 8.4.9.1. Netherlands: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. CRISPR & Cas Genes Market - Russia
- 8.4.10.1. Russia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. CRISPR & Cas Genes Market - Rest of Europe
- 8.4.11.1. Rest of Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5. CRISPR & Cas Genes Market - Asia Pacific
- 8.5.1. Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. CRISPR & Cas Genes Market - China
- 8.5.4.1. China: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.5.4.2. China: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.5.4.3. China: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. CRISPR & Cas Genes Market - India
- 8.5.5.1. India: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.5.5.2. India: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.5.5.3. India: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. CRISPR & Cas Genes Market - Malaysia
- 8.5.6.1. Malaysia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. CRISPR & Cas Genes Market - Japan
- 8.5.7.1. Japan: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. CRISPR & Cas Genes Market - Indonesia
- 8.5.8.1. Indonesia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. CRISPR & Cas Genes Market - South Korea
- 8.5.9.1. South Korea: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. CRISPR & Cas Genes Market - Australia
- 8.5.10.1. Australia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. CRISPR & Cas Genes Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6. CRISPR & Cas Genes Market - Middle East & Africa
- 8.6.1. Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. CRISPR & Cas Genes Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. CRISPR & Cas Genes Market - UAE
- 8.6.5.1. UAE: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. CRISPR & Cas Genes Market - Israel
- 8.6.6.1. Israel: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. CRISPR & Cas Genes Market - South Africa
- 8.6.7.1. South Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. CRISPR & Cas Genes Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.7. CRISPR & Cas Genes Market - Latin America
- 8.7.1. Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. CRISPR & Cas Genes Market - Mexico
- 8.7.4.1. Mexico: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. CRISPR & Cas Genes Market - Brazil
- 8.7.5.1. Brazil: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. CRISPR & Cas Genes Market - Argentina
- 8.7.6.1. Argentina: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. CRISPR & Cas Genes Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. CRISPR Therapeutics
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Editas Medicine
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Intellia Therapeutics
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Caribou Biosciences
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Sangamo Therapeutics
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Agilent Technologies
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Addgene
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Thermo Fisher Scientific
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Illumina
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Life Technologies
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Precision Biosciences
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Beam Therapeutics
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Cellectis
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Gene Editing Technologies
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Horizon Discovery
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
